Porfiromycin (NSC-56410) for disseminated squamous cancer of the cervix.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002219:Carbamates / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D002219:Carbamates